Revitalising European competitiveness through the pharmaceutical sector

The Competitiveness Compass presented by the EU Commission recognises the pharmaceutical sector’s leading role in boosting European competitiveness. There is, on the one hand, the direct effect of the value produced by the sector, and on the other hand, the indirect effect of the impact that protecting the health and well-being of citizens has on the production system. What actions are needed to ensure the sector’s autonomy, ability to innovate, readiness for crises and emergencies?
High-ranking representatives of national and European institutions will confront authoritative representatives of the pharmaceutical industry to answer the question.

Connact Pharma is organised in cooperation with the European Parliament.
The event enjoys the highest institutional patronage and will be an opportunity for meeting and dialogue on policies for the pharmaceutical sector.

Among the founding promoters of the Connact platform are Chiesi and Menarini.